US 7399862
5-HT4 receptor agonist compounds
granted A61PA61P1/00A61P1/10
Quick answer
US patent 7399862 (5-HT4 receptor agonist compounds) held by Theravance, Inc. expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P1/00, A61P1/10, A61P1/14, A61P25/00